AAIPharma Services and CritiTech, Inc. have entered a strategic alliance to expand the reach of the CritiTech’s technology. CritiTech’s nanotechnology-based offerings provide a new drug delivery option for parenteral administration, a complement to AAIPharma Services’ established oral drug delivery franchise. By opening the door for parenteral administration, the technology aims to improve the delivery of difficult-to-formulate therapeutic molecules with low aqueous solubility ...